Company Overview
SIM Acquisition Corp. I operates within the Financial Services sector, specifically classified under the industry of Shell Companies, which signifies its role as a special purpose acquisition vehicle (SPAC) designed to raise capital for a business combination rather than conducting traditional day-to-day operations. The company's primary business activity involves effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses in the healthcare sectors, although it currently does not possess significant operational assets of its own. As of the latest available data, the company holds a market capitalization of $248.17M, while its annual revenue is listed as N/A and its employee count is N/A, reflecting its status as a pre-transaction entity. The market cap of $248.17M indicates that the entity has successfully raised capital through its public offering, positioning it to pursue a merger with a target company in the healthcare industry, whereas the lack of reported revenue and employee data is consistent with the standard structure of shell companies that have not yet completed a business combination.
Financial Health
The financial profile of SIM Acquisition Corp. I reveals a net income of $9.20M over the trailing twelve months, while revenue and EBITDA are both listed as N/A, creating a distinct gap that highlights the transitional nature of the entity where income is often derived from IPO proceeds or specific transaction costs rather than operational earnings. Free cash flow is reported as N/A, which implies that the company is not currently generating cash from operations to fund growth, relying instead on its initial capital raise and cash reserves for liquidity. All three margin metrics—gross margin, operating margin, and profit margin—are recorded at 0.0%, a figure that accurately reflects the company's lack of significant operational sales and the absence of a traditional cost structure associated with delivering goods or services. The company holds $169,145 in cash, while debt and the debt-to-equity ratio are both listed as N/A, suggesting a balance sheet that is not leveraged with significant interest-bearing obligations but is also not actively generating cash to service debt. The current ratio stands at 7.68, a metric that indicates a highly liquid short-term position with current assets significantly exceeding current liabilities, providing ample buffer for upcoming transaction costs. Return on Equity and Return on Assets are both listed as N/A, which is expected for a shell company that has not yet merged with an operating business, meaning these return metrics do not yet reveal management effectiveness in generating returns from capital deployed in core operations.
Valuation Assessment
The valuation metrics for SIM Acquisition Corp. I show a P/E Ratio (TTM) and Forward P/E both listed as N/A, which implies that traditional earnings-based valuation multiples are not applicable given the absence of significant operational earnings to compare against the stock price. The price-to-book ratio is listed as -31.37, a negative figure that indicates the market is pricing the company significantly below its book value, a common characteristic for SPACs where the book value represents the trust account holding rather than operational assets. Price-to-sales ratio and EV/EBITDA are both listed as N/A, suggesting that alternative valuation metrics typically used for operating companies are not yet relevant until a target acquisition is identified and combined. The stock has traded with a 52-week high of $11.80 and a 52-week low of $10.16, meaning the current price sits within this historical range, fluctuating based on market sentiment regarding the upcoming business combination. The beta is listed as N/A, which prevents a direct comparison of price volatility relative to the broader market, though the inherent volatility of a pre-transaction SPAC is generally higher than that of established operating companies.
Growth & Income
Growth metrics for the company indicate that revenue growth year-over-year is N/A and earnings growth year-over-year is -12.6%, reflecting the decline in net income often seen as a company transitions from initial formation costs toward a potential merger target. Since earnings are listed as positive at $9.20M while revenue is N/A, the concept of earnings growing faster or slower than revenue does not apply in the traditional sense, as the income is not derived from a scalable revenue stream. The company does not pay dividends, evidenced by a dividend yield and payout ratio both listed as N/A, which confirms that all available cash and earnings are theoretically available for reinvestment into the business combination or returned to shareholders through a merger. Consequently, the overall growth and income profile is defined by the potential of the upcoming merger rather than historical growth rates or dividend yields, as the entity focuses exclusively on effecting a business combination within the healthcare sectors.